IRMD (iRadimed Corporation) Stock Analysis - Hedge Fund Holdings
iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns IRMD stock?
Hedge funds tracked by Rallies that own IRMD include Panagora Asset and Polen Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iRadimed Corporation.
IRMD Key Metrics
Key financial metrics for IRMD
Metric
Value
Price
$90.40
Market Cap
$1.13B
P/E Ratio
47.84
EPS
$1.86
Dividend Yield
0.20%
52-Week High
$107.90
52-Week Low
$46.86
Volume
13
Avg Volume
0
Revenue (TTM)
$86.28M
Net Income
$23.61M
Gross Margin
76.83%
Top Hedge Funds Holding IRMD
Panagora Asset holds 25.68K shares of IRMD, changed +0.00% as of Dec 31, 2023.
Polen Capital holds 20.74K shares of IRMD, changed -22.86% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own IRMD include Panagora Asset and Polen Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for iRadimed Corporation.
Does Rallies show 13F holders for IRMD?
Yes. Rallies tracks hedge fund and 13F ownership data for IRMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
